Multifactorial trials: taking apart the kitchen sink

Understanding science is hard.

Interpreting a study correctly, weighing its limitations, and resisting the pull toward the most convenient or exciting conclusion is not intuitive. It is a skill developed over years of training. That is not a criticism of anyone who gets it wrong. It is exactly why we did an entire podcast episode on how to think scientifically: because the gap between “reading a study” and “correctly interpreting a study” is enormous, and almost nobody is taught how to close it.

One version of this gap that I have seen more and more lately is a specific kind of cherry-picking: taking a multifactorial trial and crediting, or blaming, a single ingredient inside it for the whole result.

The kitchen sink design

Here is the pattern. Investigators want to know whether a lifestyle intervention improves some health outcome—say, blood pressure. So they throw everything they can at a group of participants: eat more fruits and vegetables, increase protein intake, practice mindfulness, spend more time in nature, and follow a structured exercise program. A kitchen sink of interventions, all at once. The control group receives usual care.

After six months, the intervention group has lower blood pressure than the control group.

What can we conclude from that? Much less than most people think.

There are several different stories that are all completely consistent with that same result. Maybe all five components contributed. Maybe only one component mattered, and the other four were along for the ride. Maybe one component actually raised blood pressure, but the others more than compensated. Or maybe none of the components works on its own, but several become effective only when combined.

All of these possibilities are compatible with the data.

The one thing we absolutely cannot say, from a trial designed this way, is that any single component, on its own, lowered blood pressure. In a study designed this way, the investigators cannot distinguish among these possibilities, or the dozens of variations in between.

And yet the headline that runs is almost never: “A bundle of things we can’t disentangle lowered blood pressure.”

It is: “Mindfulness lowers blood pressure,” or “Spending time in nature lowers blood pressure,” or “Exercise lowers blood pressure”—whichever component happens to be the most interesting, novel, or aligned with what the person writing the headline already wanted to believe.

To see how absurd this can get, imagine the same trial design, but let’s substitute out only the conventional exercise program. Instead of lifting weights or going for a walk, participants are asked to stand on one leg for 5 minutes while wearing a wizard’s hat. 

If blood pressure drops in the intervention group, the study has done nothing to rule out “standing on one leg while wearing a wizard’s hat lowers blood pressure” as a possible headline. It sounds ridiculous, and it is, but it’s not a different kind of error than “eating more fruits and vegetables lowered blood pressure” or “mindfulness lowered blood pressure” pulled from the exact same design. The only reason the wizard hat version sounds absurd and the vegetable version doesn’t is that we already have prior beliefs about which of these interventions is biologically plausible. The trial itself gave us no such information.

And that is exactly the point. Being included in a successful package does not make something causal. Being included in a successful package does not even make something matter.

Where the stakes stop being academic

If every component of a lifestyle package were free, harmless, and without opportunity cost, I would care much less about parsing the active ingredient. Walking after dinner, getting morning light, calling a friend, and spending more time outdoors are all low-risk bets. Even if we do not know which component did what, most people are unlikely to be harmed by adopting a bundle of low-risk, low-resource interventions.

But not all interventions are costless. Some require major dietary restrictions. Some are hard to adhere to. Some affect quality of life. Some displace behaviors that may matter more. Some introduce nutritional tradeoffs.

This is where causal attribution becomes more than an academic concern. 

Consider a comprehensive lifestyle trial that includes a recommendation to substantially reduce or eliminate animal protein. For someone with an ethical objection to eating animal products, that may already be aligned with their values or dietary habits. But for someone without that objection, it is a major intervention, with potential implications for adherence, quality of life, protein adequacy, and preservation of muscle mass and function with age.

If eliminating animal protein is essential to stabilizing or reversing cognitive decline, we need to know that. But we can only know it from a study specifically designed to isolate that variable. A trial that changes ten things at once cannot tell us whether that component helped, did nothing, or even worked against the benefit of the others. 

Multifactorial trials aren’t useless—they just get overinterpreted

I want to be clear that I am not making a case against multifactorial trials generally. There are many situations where a comprehensive overhaul is exactly what should be studied.

Fixing one aspect of your diet is not going to prevent Alzheimer’s disease. Nor is one supplement, one breathing exercise, or one biomarker tweak likely to reverse a complex chronic disease. Many of the conditions we care about most—cardiovascular disease, diabetes, dementia, cancer, frailty—emerge from many interacting systems over many years. Testing a single lever in isolation may fail to produce a detectable effect even if a combination of levers would.

Kitchen-sink trials can test something closer to real life. They can preserve potential synergy among components, and they can be especially useful when the intervention is made up of low-cost, low-risk behaviors that no pharmaceutical company will ever market.

They can also be incredibly valuable for generating hypotheses. A multifactorial intervention can identify a signal, show us where to look next, and justify the harder, more targeted trials that follow.

But in this case they are the beginning of the process—not the end.

If a multifactorial intervention improves cognition, blood pressure, or metabolic health, the next question should be: which components are doing the work? Which are necessary? Which are optional? Which are synergistic? Which are costly but irrelevant?

This is why reductionist trials still matter. They are the trials that turn a broad observation into a useful recommendation. While they are not always glamorous, and they do not always capture the full complexity of real life, when they are well designed, they can isolate a single variable and tell us what is actually important.

When you change everything at once, you learn something about everything at once.

When you change one thing and measure the result, you learn something about that thing.

Both can be useful. But it is a mistake to think they are the same.

The bottom line

The rule I wanted to highlight today is simple: do not let the conclusion outrun the design.

Every study deserves to be interpreted at exactly the level of certainty its design can support. No higher, and no lower.

If a study tests a bundle, the conclusion should be about the bundle. If a study is observational, the conclusion should be about an association. If a study does not isolate a variable, the conclusion should not pretend that it did.

Science often gives us clues before it gives us answers—our job is to treat clues as clues. The problem begins when we mistake the map for the treasure.

A kitchen-sink study can tell us the kitchen sink worked. It cannot tell us which component mattered. And when someone points to one component in a ten-part intervention and says, “That is the thing that caused the benefit,” the right response is not acceptance of whatever confirms our existing beliefs.

The right response is the most basic scientific question: How could you possibly know?

For a list of all previous weekly emails, click here. 

podcast | website | ama